Capstone Investment Advisors
RDY icon

Capstone Investment Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Capstone Investment Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22,290
Closed -$340K – 2152
2024
Q2 		$340K Buy
+22,290
New +$319K ﹤0.01% 1519
2023
Q4 		– Sell
-37,290
Closed -$499K – 2354
2023
Q3 		$499K Buy
+37,290
New +$505K ﹤0.01% 1326

Other funds holding RDY

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Capstone Investment Advisors's RDY Position: Q3 2024 in Review

Capstone Investment Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q3 2024, closing a stake of 22,290 shares — an estimated $340K sold.

Capstone Investment Advisors first reported a position in RDY in Q3 2023 and held it in 2 quarters. The position peaked at $499K in Q3 2023. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2024.

  • Capstone Investment Advisors reported no remaining Dr. Reddy's Laboratories position as of Q3 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 22,290 Dr. Reddy's Laboratories shares in Q3 2024, an estimated $340K.
  • Capstone Investment Advisors first reported a position in Dr. Reddy's Laboratories in Q3 2023 and held it in 2 quarters.
  • Capstone Investment Advisors's Dr. Reddy's Laboratories position peaked at $499K in Q3 2023.
  • 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2024.

Based on Capstone Investment Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.